Basel Medical Group (BMGL) Stock Price, News & Analysis

Company Overview

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.

Key Stats

• Today's Range: $6.14 to $6.50
• 50-Day Range: $5.82 to $9.16
• 52-Week Range: $4.60 to $54.60
• Volume: 5,214 shs
• Average Volume: 22,461 shs
• Market Capitalization: $9.58 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Basel Medical Group Stock Analysis - MarketRank™

Basel Medical Group scored higher than 21% of companies evaluated by MarketBeat, and ranked 776th out of 852 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Basel Medical Group has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Basel Medical Group has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Basel Medical Group has a P/B Ratio of 2.52. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.81% of the float of Basel Medical Group has been sold short.

Short Interest Ratio / Days to Cover

Basel Medical Group has a short interest ratio ("days to cover") of 1.01, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Basel Medical Group has recently decreased by 95.97%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Basel Medical Group does not currently pay a dividend.

Dividend Growth

Basel Medical Group does not have a long track record of dividend growth.

News and Social Media

• Score: 3.5 / 5
• News Sentiment: 0.61

News Sentiment

Basel Medical Group has a news sentiment score of 0.61. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.87 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 7 news articles for Basel Medical Group this week, compared to 1 article on an average week.

Search Interest

2 people have searched for BMGL on MarketBeat in the last 30 days.

MarketBeat Follows

1 people have added Basel Medical Group to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Basel Medical Group insiders have not sold or bought any company stock.

Percentage Held by Institutions

Basel Medical Group has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 6/26/2026
• Today: 7/13/2026
• Fiscal Year End: 6/30/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:BMGL
• CIK: 2004489
• Web: N/A
• Phone: (656) 291-9188
• Fax: N/A
• Employees: 36
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.93
• Current Ratio: 1.88
• Quick Ratio: 1.83

Sales & Book Value

• Annual Sales: $8.90 million
• Price / Sales: 1.08
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $2.44 per share
• Price / Book: 2.52

Miscellaneous

• Outstanding Shares: 1,560,000
• Free Float: N/A
• Market Cap: $9.58 million
• Optionable: N/A
• Beta: 0.15